Document Page: First | Prev | Next | All | Image | This Release | Search
File: 082696_doc1_476.txt
o ~.commend Septra ordoxycycline, on. tablet daily
o Prophylaxti will not be e+~ective 1+ organism `has
been ~enetically ma ipulated to render it res~stant
o Renistance against or+loxacin/cipro~loxacin less
likely, but may be better to hold this in reserve
+or treatment
o Vaccination
o Would not recommen~j currently avai~able vaccine;
not very e++ecttve and not likely to be e++.ctive
under BW conditions
o Procurement
o Need ~dditional oral Septra-DS and doxycycline
- ~OQ tabs o+ each +or 100 individuals,
assuming a ~ day exposure
- Could be either Septra-DS or doxycycline
but will need to allow +or allergies
o Need nor+loxacin ofl cipro+lo}cactn in the +teld or
readily available ~or treatment +ailures, and
possibly prophylaxis
- Minimum o~ tOO 400 mg nor+loxacin tablets +or
too individuals +or one course 0+ treatment,
or 1200 2~O m~ cipro+loxacin tablets (600
~OO m~ tablets)
0 Lo~istics
o No comments
o ~xporta~le trainin~ program
o ~imple handout should su+~ice
o Other critical issues
o Non.
UNtTS T~R~~T~D ~OR PROTECTION
o No recommendationsi this is an operational/intelligence
dec 1 Si On
OTHER CRITIC~L ~SSUEB
o None
RECOMMENO~T I ON~
o Protect +ood/water sources ~rom delib~rate contamination
o Us. prophylactic antibiotics 1+ exposure is tmmine~t or
con+ I rmed
5
Document Page: First | Prev | Next | All | Image | This Release | Search